Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study

Background: non-small cell lung cancer (NSCLC) outcomes remain suboptimal for early-stage disease despite emerging advances in systemic therapy for the peri-operative period. Next-generation sequencing (NGS) identifies driver mutations for which targeted therapies have been developed that improve su...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilzenrat, Roy Avraham, Yip, Stephen, Melosky, Barbara, Ho, Cheryl, Laskin, Janessa, Sun, Sophie, Choi, James J., McGuire, Anna L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858228/
https://www.ncbi.nlm.nih.gov/pubmed/36661661
http://dx.doi.org/10.3390/curroncol30010012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858228/
https://www.ncbi.nlm.nih.gov/pubmed/36661661
http://dx.doi.org/10.3390/curroncol30010012

Ejemplares similares